FLT3 and acute myeloid leukemia: In case of AML relapse, with detection of either FLT3-ITD or FLT3-TKD mutations at primary diagnosis, confirmation of the FLT3 mutational status is required, because clonal evolution can confer the loss of activating mutations at relapse [16,17].